|View printer-friendly version|
|Array BioPharma to Present at the William Blair Small-Cap Growth Stock Conference|
|BOULDER, Colo., Sep 29, 2008 (BUSINESS WIRE) -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief
Executive Officer, Robert E. Conway, will speak at the William Blair
Small-Cap Growth Stock Conference on October 7 in New York City. The
public is welcome to participate in the conference through a webcast on
the Array BioPharma website.
Event: William Blair Small-Cap Growth Stock Conference
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, inflammatory diseases, pain and metabolic diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. For more information on Array, please go to www.arraybiopharma.com.
SOURCE: Array BioPharma Inc.
Array BioPharma Inc.